Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Mitesco, Inc.MITI · Entity 8540 | Director · Chief Financial Officer | November 29, 2022 | December 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Mitesco, Inc.
Report date November 29, 2022 · Filed December 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Purchase WarrantSEC Table II · derivative / convertible security · Expires 2027-11-29 | Direct | 37,500 |
Reported balance
After 2022-11-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-11-29 · Purchase · Acquired 37,500 · Balance 37,500 F1: On November 29, 2022, Mitesco, Inc. (the "Company") issued a 10% promissory note (the "Note") to Thomas Brodmerkel. The principal amount of the Note is $18,750 and carries a 10% interest rate per annum. 37,500 Common Stock Purchase Warrants were granted to Mr. Brodmerkel on November 29, 2022, pursuant to the Note at an exercise price priced at the same price as included in an offering in conjunction with listing at the Nasdaq Global Market. The Warrants are exercisable at any time on or after May 29, 2023, and on or before the November 29, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 29, 2022, Mitesco, Inc. (the "Company") issued a 10% promissory note (the "Note") to Thomas Brodmerkel. The principal amount of the Note is $18,750 and carries a 10% interest rate per annum. 37,500 Common Stock Purchase Warrants were granted to Mr. Brodmerkel on November 29, 2022, pursuant to the Note at an exercise price priced at the same price as included in an offering in conjunction with listing at the Nasdaq Global Market. The Warrants are exercisable at any time on or after May 29, 2023, and on or before the November 29, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2022 Filed Dec 6, 2022 16:09 UTC | Mitesco, Inc. MITI · Entity 8540 | PurchaseCommon Stock Purchase Warrant · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001185185-22-001387 · ownership.xml · derivative · entry 1 Brodmerkel Thomas · CIK 0001817747 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2027-11-29 F1 · derivative.exercise_price: On November 29, 2022, Mitesco, Inc. (the "Company") issued a 10% promissory note (the "Note") to Thomas Brodmerkel. The principal amount of the Note is $18,750 and carries a 10% interest rate per annum. 37,500 Common Stock Purchase Warrants were granted to Mr. Brodmerkel on November 29, 2022, pursuant to the Note at an exercise price priced at the same price as included in an offering in conjunction with listing at the Nasdaq Global Market. The Warrants are exercisable at any time on or after May 29, 2023, and on or before the November 29, 2027. F1 · shares: On November 29, 2022, Mitesco, Inc. (the "Company") issued a 10% promissory note (the "Note") to Thomas Brodmerkel. The principal amount of the Note is $18,750 and carries a 10% interest rate per annum. 37,500 Common Stock Purchase Warrants were granted to Mr. Brodmerkel on November 29, 2022, pursuant to the Note at an exercise price priced at the same price as included in an offering in conjunction with listing at the Nasdaq Global Market. The Warrants are exercisable at any time on or after May 29, 2023, and on or before the November 29, 2027. Read SEC document |
| June 11, 2021 Filed Jun 22, 2021 19:03 UTC | Mitesco, Inc. MITI · Entity 8540 | Exercise / conversionStock Option · Derivative | 416,667 | $0.00 Strike: $0.03 | $0.00 |
DisclosureSEC source: 0001185185-21-000845 · ownership.xml · derivative · entry 2 Brodmerkel Thomas · CIK 0001817747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,666 Underlying: Common Stock · 416,667 shares Expires 2030-12-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2021 Filed Jun 22, 2021 19:03 UTC | Mitesco, Inc. MITI · Entity 8540 | Exercise / conversionCommon Stock | 416,667 | $0.03 | $12,500.01 |
DisclosureSEC source: 0001185185-21-000845 · ownership.xml · nonDerivative · entry 1 Brodmerkel Thomas · CIK 0001817747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 17, 2021 13:13 UTC | Mitesco, Inc. MITI · Entity 8540 | GrantEmployee Stock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $0.22 | $0.00 |
DisclosureSEC source: 0001185185-21-000820 · ownership.xml · derivative · entry 1 Brodmerkel Thomas · CIK 0001817747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2031-06-07 F1 · derivative.exercise_date: These stock options vest pro rata on a monthly basis over 12 months. Read SEC document |
| December 27, 2020 Filed Jan 25, 2021 14:23 UTC | Mitesco, Inc. MITI · Entity 8540 | GrantCommon Stock · Derivative | 100,000 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001185185-21-000108 · ownership.xml · derivative · entry 3 Brodmerkel Thomas · CIK 0001817747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-26 F1 · price: The options reflected in the chart above were issued in exchange for services rendered by the Reporting Person as a director of the Issuer. All options reflected in the Table above have vested. Read SEC document |
| February 27, 2020 Filed Jan 25, 2021 14:23 UTC | Mitesco, Inc. MITI · Entity 8540 | GrantCommon Stock · Derivative | 833,333 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001185185-21-000108 · ownership.xml · derivative · entry 2 Brodmerkel Thomas · CIK 0001817747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 833,333 shares Expires 2030-12-26 F1 · price: The options reflected in the chart above were issued in exchange for services rendered by the Reporting Person as a director of the Issuer. All options reflected in the Table above have vested. Read SEC document |
| February 27, 2020 Filed Jan 25, 2021 14:23 UTC | Mitesco, Inc. MITI · Entity 8540 | GrantCommon Stock · Derivative | 166,667 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001185185-21-000108 · ownership.xml · derivative · entry 1 Brodmerkel Thomas · CIK 0001817747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,667 Underlying: Common Stock · 166,667 shares Expires 2030-12-26 F1 · price: The options reflected in the chart above were issued in exchange for services rendered by the Reporting Person as a director of the Issuer. All options reflected in the Table above have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.